|1||NCT02469857||Recruiting||Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections||
||Industry / U.S. Fed||
||290||All||12 Years and older (Child, Adult, Senior)||NCT02469857||ATB-202||ACCUTE||September 2015||December 2018||March 2019||June 12, 2015||November 28, 2017||
|2||NCT03108456||Recruiting||Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial||
||Industry / Other||
||2000||All||18 Years and older (Adult, Senior)||NCT03108456||CLN-0011-P||ECLIPSE||March 27, 2017||December 31, 2020||December 31, 2021||April 11, 2017||April 10, 2018||
† Study has passed its completion date and status has not been verified in more than two years.